METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinoma

Overview of attention for article published in Frontiers in Cell and Developmental Biology, September 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 9 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 10,973 followers.

Pubmed: METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinoma https://t.co/nV3SKucTGj

27 Sep 2022

Reply Repost Favourite

New Research: METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinoma: Pancreatic carcinogenesis is a complicated and multi-step process. It is substantially assisted by N6-methyladenosine (m6A)… https://t.co/

10 Sep 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.